The Middle EAST Tenecteplase Drug Market was valued at USD 0.15 billion in 2024 and is projected to reach USD 0.45 billion by 2034, registering a CAGR of 12.0%. This growth trajectory is underpinned by several key factors, including the rising incidence of cardiovascular diseases, increasing awareness regarding thrombolytic therapies, and advancements in medical technology. The demand for...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek